Tweets

February 19

The key takeaways from some recent blockbuster patentability cases from the Fed Circuit https://t.co/BT95Uj7Grz

February 19

Come and meet IP leaders from the Auto Industry to learn, share best practice and discuss new ways to exploit and p… https://t.co/K90wCUzwKd

February 19

Patent owners have little to worry about in JPO plans for SEP reviews. https://t.co/Cfp3RZOL1H

Blog

19 Feb 2018
Blockbuster Fed Circuit 101 decision gives patent owners a boost

In the almost four years since the Supreme Court added to its jurisprudence around patentability in Alice Corp v CLS Bank, the Court of Appeals for the Federal Circuit (CAFC) has been steadily filling in the blanks on what exactly constitutes patent eligible subject matter - particularly when it comes to computer-implemented inventions. The court has tinkered less with the actual process...

19 Feb 2018
JPO details plan to review SEP essentiality, but there may be little scope for implementers to use it defensively

The Japan Patent Office (JPO) last week unveiled a new service that will see it weigh in on the standing of Japanese patents declared standards essential. When it was first announced last November, this system was perceived as offering a defensive tool to implementers. But the draft guidelines for the scheme, helpfully translated in part here by Satoshi Watanabe of Watanabe Research and...

17 Feb 2018
Poor patent quality, biosimilars, third-party disputes, Brexit and more from our pharma and biotech event

Last week, life sciences patent professionals from around the world gathered at London’s Hallam Conference Centre for IAM’s second annual Pharma and Biotech IP Summit – the first ever IAM event to be held on UK home turf. Delegates – and there were twice as many in attendance than were at our first summit in Munich in 2016 – were treated to insightful...

Explore the current issue

Intellectual property and artificial intelligence: what does the future hold?

Artificial intelligence is creating a seismic shift in the way that people interact with technology. Research institutions and for-profit companies are moving to patent the commercial aspects of this new area in a land grab which could see rights holders reap future benefits
Peter Cowan and Jim Hinton

The world's leading patent professionals

IAM Patent 1000

The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.

Visit site

The world's leading IP strategists

IAM Strategy 300

A directory of individuals identified following a detailed research process as global leaders in providing IP value creation expertise to rights owners.

Visit site
IAM Market
Market intelligence

Market intelligence

Annual IAM supplements and management reports that take an in-depth look at specific areas of IP value creation concern and opportunity.

Visit site
IPBC

IPBC

Unique in the global IP marketplace, IPBC events bring together corporate leaders, aggregators, investors and other intermediaries to discuss key issues, network and do deals.

Visit site
IP Hall of Fame

IP Hall of Fame

A project designed to recognise the outstanding contributions that individual men and women have made towards the creation of today’s global IP system.

Visit site
Upcoming event

Upcoming event

Pharma and Biotech IP Summit 2018
February 8 2018 - London 
IAM's second annual event for senior patent executives in the life sciences industry. 
 

View all events
Subscribe

Subscribe

IAM is a unique publication which focuses on the many ways in which intellectual property and intangible assets can be used to create corporate value.

Subscribe now
International reports

International reports

Weekly updates from IAM’s team of international correspondents looking at recent developments in IP law and practice, business and finance.

Visit site